Scientists discover surprise benefit of Ozempic that could transform lives of millions with common skin disease READ MORE: Proof Ozempic really IS life-saving, slashing deaths by a quarter By Kate Pickles Health Editor For The Daily Mail Published: 23:00, 24 September 2024 | Updated: 23:00, 24 September 2024 e-mail View comments Weight loss jabs can ease symptoms of a common skin condition, new research suggests. Hidradenitis Suppurative (HS) is a chronic condition which can lead to abscesses and scarring, affecting around on in 100 people. Treatment with semaglutide – the key ingredient in Wegovy and Ozempic – was found to significantly reduce painful flare-ups.
Obese patients who had varying levels of HS were given a weekly jab at low average dose of 0.8mg for around eight months. In addition to weight loss, the blockbuster weight loss drugs have been found to slash the chances of heart attack and stroke, as well as other diseases.
Researchers monitored changes in body mass index (BMI), weight, flare frequency, pain and Dermatology Life Quality Index (DLQI) – a score used to assess the overall impact of symptoms. They also looked at biochemical markers, including blood sugar and C-reactive protein (CRP) levels, a measure of inflammation. Typically, flare-ups reduce from once every 8.
5 weeks to once every three months, according to the findings presented at the European Academy of Dermatology and Venereology (EADV) Congress Quality of life also improved significantly, .
